Hologic has launched its Novodiag system in Europe. The Waltham, MA-based company inherited the automated molecular diagnostic solution for on-demand testing of infectious diseases and antimicrobial resistance when it acquired Mobidiag Oy for $795 million.

Roche said on Wednesday that three of its molecular respiratory panels have received CE marking and have been launched in countries accepting the CE mark.

Identifying the genetic cause of epilepsy using whole genome sequencing could lead to better disease management.

HTG Molecular said on Thursday that it has signed three new European distribution agreements to promote its products and services in Nordic and Eastern Europe countries. The Tucson, Arizona-based firm signed agreements with Denmark-based Bi

NEW YORK HTG Molecular Diagnostics reported after the close of the market on Wednesday an 11 percent year-over-year drop in its full-year revenues, driven by a significant decrease in collaboration revenue. For the year ended Dec. 31, 2019,

The global molecular diagnostics market is expected to grow at a CAGR of8.4% from USD 7.71 billion in 2018 to USD 11.54 billion by 2023, driven by theincreasing prevalence of infectious diseases and various types of cancers,rising awareness